
Sign up to save your podcasts
Or


Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance. Related Content:
By JAMA Network4.4
469469 ratings
Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance. Related Content:

142 Listeners

320 Listeners

699 Listeners

163 Listeners

295 Listeners

261 Listeners

3,366 Listeners

38 Listeners

20 Listeners

13 Listeners

12 Listeners

8 Listeners

16 Listeners

19 Listeners

5 Listeners

6 Listeners

21 Listeners

1,151 Listeners

29 Listeners

196 Listeners

9 Listeners

92 Listeners

14 Listeners

5 Listeners

516 Listeners

5 Listeners

361 Listeners

253 Listeners

426 Listeners

106 Listeners

18 Listeners

373 Listeners

2 Listeners